N-Nitroso Escitalopram EP Impurity D/N-Nitroso Desmethylcitalopram
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Escitalopram is used to treat depression and generalized anxiety disorder (GAD). It is an antidepressant that belongs to a group of medicines known as selective serotonin reuptake inhibitors (SSRIs). These medicines work by increasing the activity of the chemical serotonin in the brain.N-Nitroso Escitalopram EP Impurity D is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Escitalopram EP Impurity D CAS NO:NA chemically represented as N-(3-(5-Cyano-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-1-yl)propyl)-N-methylnitrous amide and it is also known as N-Nitroso Desmethylcitalopram .Synchemia is the leading manufacturing and exporter of N-Nitroso Escitalopram EP Impurity D.We supply N-Nitroso Escitalopram EP Impurity D with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143525 |
| CAS No | NA |
| Mol.F. | C15H18N4O4 |
| Mol.Wt. | 318.33 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143526 |
| CAS No | NA |
| Mol.F. | C14H16N4O3 |
| Mol.Wt. | 288.31 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143527 |
| CAS No | NA |
| Mol.F. | C15H18N4O4 |
| Mol.Wt. | 318.33 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143528 |
| CAS No | NA |
| Mol.F. | C12H15N3O4 |
| Mol.Wt. | 265.27 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143529 |
| CAS No | NA |
| Mol.F. | C7H8ClN3O3 |
| Mol.Wt. | 217.61 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143530 |
| CAS No | NA |
| Mol.F. | C15H18N4O3 |
| Mol.Wt. | 302.33 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143531 |
| CAS No | NA |
| Mol.F. | C15H20N4O3 |
| Mol.Wt. | 304.35 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143531 |
| CAS No | NA |
| Mol.F. | C15H20N4O3 |
| Mol.Wt. | 304.35 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143532 |
| CAS No | NA |
| Mol.F. | C15H19ClN4O2 |
| Mol.Wt. | 322.79 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143533 |
| CAS No | NA |
| Mol.F. | C15H19ClN4O2 |
| Mol.Wt. | 322.79 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143534 |
| CAS No | NA |
| Mol.F. | C23H29N5O2 |
| Mol.Wt. | 407.52 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143535 |
| CAS No | NA |
| Mol.F. | C15H17ClN4O2 |
| Mol.Wt. | 320.78 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143536 |
| CAS No | NA |
| Mol.F. | C23H27N5O2 |
| Mol.Wt. | 405.50 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143537 |
| CAS No | NA |
| Mol.F. | C23H27N5O2 |
| Mol.Wt. | 405.50 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143538 |
| CAS No | NA |
| Mol.F. | C15H18N4O4 |
| Mol.Wt. | 318.33 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143539 |
| CAS No | NA |
| Mol.F. | C15H18N4O4 |
| Mol.Wt. | 318.33 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |